Lori Helgeson

Lori Helgeson is an experienced executive in the field of ophthalmology, currently serving as Executive Director and Clinical Portfolio Lead at Aura Biosciences since May 2023. Prior to this role, Lori held the position of Executive Director for Therapeutic Strategy Implementation at Worldwide Clinical Trials, focusing on enhancing operational excellence in Ophthalmology Rare Diseases. From October 2018 to May 2022, Lori was the Executive Director of Ophthalmology Clinical Development at Syneos Health Clinical Solutions, where responsibilities included client portfolio strategy and oversight of ophthalmology research. Lori's earlier experience includes Senior Director of Clinical Operations at Ora, Inc. and Senior Project Director at INC Research. Lori's academic background includes studies at Georgia State University Perimeter College from 1993 to 1995.